SCHEMBL1418147

SCHEMBL1418147

CCn1c(-c2ccc3c(c2)C(=O)N=C3)nnc1C(C)(C)Oc1c(F)cc(F)cc1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1417454 0.93 METAP2 (0.30)
SCHEMBL1418148 0.81 CLK4 (0.40)
SCHEMBL1417456 0.80 DAPK3 (0.44)
SCHEMBL7984625 0.79 KDM4E (0.36)
SCHEMBL7988052 0.78 CDK8 (0.34)
SCHEMBL12671338 0.77 CYP11B1 (0.36)
SCHEMBL7984537 0.77 CCNC (0.31)
SCHEMBL7982928 0.77 MAPK14 (0.39)
SCHEMBL7980163 0.76 P2RX7 (0.36)
SCHEMBL7980172 0.76 CYP1A2 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2298747-B1 TRIAZOLE DERIVATIVE OR SALT THEREOF ASTELLAS PHARMA INC (JP) 2016-12-28 EP disclosed
US-8377923-B2 Triazole derivative or salt thereof ASTELLAS PHARMA INC. (JP) 2013-02-19 US disclosed
US-20110105460-A1 TRIAZOLE DERIVATIVE OR SALT THEREOF ASTELLAS PHARMA INC. (JP) 2011-05-05 US disclosed
EP-2298747-A1 TRIAZOLE DERIVATIVE OR SALT THEREOF Astellas Pharma Inc. (JP) 2011-03-23 EP disclosed